National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025
The new guideline introduces key practice changes including broader recognition of ECG patterns of ACOMI, integration of hs-cTn testing into clinical decisions pathways and selective use of intravascular imaging in NSTEACS. Updated P2Y<sub>12</sub> inhibitor timing, stricter LDL-C targets and PCSK9 inhibitor use support more tailored and evidence-based care in the secondary prevention of ACS. The full guideline is available at www.heartfoundation.org.au/for-professionals/acs-guideline.
Authors
- Louise Cullen (ORCID: https://orcid.org/0000-0001-6611-8229)
- Victoria D. Leitch (ORCID: https://orcid.org/0000-0001-5760-2887)
- Tom Briffa
- Cynthia Papendick (ORCID: https://orcid.org/0000-0002-1648-7672)
- Dannii Dougherty
- Ian Scott
- Sarah Zaman (ORCID: https://orcid.org/0000-0002-7698-0397)
- Garry Jennings
- E. Ho
- David B. Brieger
Institutions
- Royal Adelaide Hospital (AU)
- The University of Queensland (AU)
- The University of Western Australia (AU)
- National Heart Foundation of Australia (AU)
- Royal Brisbane and Women's Hospital (AU)
- Concord Repatriation General Hospital (AU)
- Princess Alexandra Hospital (AU)
- Westmead Institute (AU)
- Australian e-Health Research Centre (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- The Medical Journal of Australia
- Published
- 2026-02-01
- DOI
- https://doi.org/10.5694/mja2.70127
- Citations
- 1
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 30.07
Funders
- National Heart Foundation of Australia
- Cardiac Society of Australia and New Zealand